$UWMC lost $600m hedging a deal they'd already lost
UWMC booked a roughly $600 million Q2 hedging loss tied to TWO months after the deal collapsed, contributing to an expensive capital raise.
Tuesday, August 11, 2026
Investor Letters
All letters- Upslope Capital Management Q2 2026 -6.6%
- Rowan Street Capital The first half of 2025 +20.1%
- RGA Investment Advisors Q1 2026
- Heartland Advisors 1Q26 +7.4%
- Massif Capital Fourth Quarter 2025 +9.6%
- Pershing Square Holdings Six-month period ended June 30, 2025 +15.5%
- Pershing Square Holdings 2025 +20.9%
- Horizon Kinetics 2nd Quarter 2024
- Askeladden Capital Q2 2025
- Berkshire Hathaway 2024 +25.5%
- Palm Valley Capital Third Quarter 2025 +2.4%
- Palm Valley Capital Fourth Quarter 2025 +0.7%
- Palm Valley Capital First Quarter 2026 +0.7%
Alphabet Inc. ($GOOGL) - Deep Dive
Alphabet's Google Cloud swung from a $3.1 billion operating loss in 2021 to $13.9 billion profit in 2025 as Search revenue grew 13.2%.
[V, MA] The more things change, the more they stay the same
Visa and Mastercard have absorbed digital wallets and BNPL into their networks, using global merchant acceptance to turn supposed…
Shopify 2Q'26: Sustained Miraculous Growth
Shopify sustained 30% FX-neutral GMV growth in 2Q’26, reaching roughly 44% of Amazon’s retail GMV as international, POS and B2B volumes…
SpaceX Disappoints, AI's Free Cash Flow Shrinks, Meta Struggles | The Weekly Wrap
Steve Eisman reviews SpaceX earnings, AI capital spending’s drag on free cash flow, Meta’s struggles, and the collapse of Situational…
$HIMS: Paul Cerro wouldn't trust the CEO to walk his dog. He's still long. Why? | Cedar Grove
Hims & Hers investor Paul Cerro is long again on lab and patient data driving retention and LTV, despite management concerns, GLP-1…
Airbnb 2Q'26: Widening the Gap with Booking
Airbnb added 14 million booked nights and seats, up 10%, and guided low-double-digit third-quarter growth as North America and EMEA…
[scuttleslops] BKNG, ABNB, SHOP, LPX, TREX, XYZ
Booking Holdings beat Q2 guidance as room nights grew 5%; connected trips, merchant payments and Genius loyalty strengthened direct…
Coupang: 2Q26 Business Recap
Coupang’s product-commerce revenue rose 8% in constant currency as data-leak churn lingered, while promotions and underused logistics…
Perimeter Solutions: 2Q26 Business Recap
Perimeter Solutions’ 2Q26 revenue rose 31%, while operating income fell 11% as USDA pricing and DLA delivery timing hurt Fire Safety; it…
Floor & Decor: 2Q26 Business Update
Floor & Decor’s same-store sales improved to minus 2%, while $45 million of tariff refunds lifted second-quarter gross profit and operating…
The writers we follow
Every source on this site, hand-picked.
- mavix
- Wolf's Substack
- Seeking Alpha
- Raging Capital Ventures
- David Orr
- Chris Camillo
- MBI Deep Dives
- BDC
- Triple S Special Situations Investing
- Connor Haley
- Ian Bezek
- Timyan Bank Alert
- AltayCap
- Yet Another Value Podcast
- Yet Another Value Blog
- Nat Stewart
- scuttleblurb
- The Oak Bloke
- Mike
- JabroniCoin.USD
- The Monetary Matters Network
- Steve Eisman
- Tim Eriksen
- Bristlemoon Capital
- Bearhold Research
- 310 Value’s Newsletter
- marginofdanger
- The Value Road
- Capital Employed
- Speedwell Memos
- Psyop Capital
- Laughing Water Capital
- The Mikro Kap
- catechwilliams
- Treasure Hunting
- Porter Collins
- Clark Street Value
- Cluseau Research
- John Hempton's Newsletter
- Undervalued Shares
- Value Investors Club
- smallvalue.
- Maius Partners
- Multibagger Monitor
- Altay Capital - Mostly Value Investing
- Nat Stewart - Stock Picking Newsletter
- Citrini Research
- Rusholme Capital
- Hunterbrook No stories
- Odds on Open No stories
- Sunday's Idea Brunch No stories
Older Stories
BLDR 2026-08-03 
[scuttleslops] BLDR, RYAN, APG, GFL, FND
scuttleblurb Vistance Networks (NASDAQ: VISN)
Triple S Special Situations Investing AXT’s Tongmei Problem: Great Asset, Fragile Economics
Maius Partners The last Bristol Myers' blog post was wrong on the core thesis
John Hempton's Newsletter A non-consensus thesis: the forthcoming demise of Bristol Myers Squibb.
John Hempton's NewsletterTopics
Ordered by how often our editor reaches for them.
